Follow The Filings

TNON Tenon Medical

Tenon Medical earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -12.35 —
Rev — $1.3M —

Insider trades

Open-market buys and sales by TNON's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TNON insider trades
  • $500K bought by 4 insiders
  • $606K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Hrt Financial LP 10% owner
    Buy
    $383K 108,140 shares at $3.54 New stake
    Traded Sep 8–10 Filed Sep 11
  2. Hrt Financial LP 10% owner
    Sale
    $539K 125,925 shares at $4.28 89% of stake
    Traded Sep 9–10 Filed Sep 11
  3. Hrt Financial LP 10% owner
    Buy
    $6,599 1,658 shares at $3.98 +92% to stake
    Traded Sep 3 Filed Sep 8
  4. Hrt Financial LP 10% owner
    Sale
    $5,572 1,506 shares at $3.70 44% of stake
    Traded Sep 4 Filed Sep 8
  5. Hrt Financial LP 10% owner
    Buy
    $8,180 1,790 shares at $4.57 +394% to stake
    Traded Sep 1 Filed Sep 3
  6. Hrt Financial LP 10% owner
    Sale
    $2,039 450 shares at $4.53 20% of stake
    Traded Sep 2 Filed Sep 3
  7. Hrt Financial LP 10% owner
    Buy
    $102K 18,357 shares at $5.58 New stake
    Traded Aug 28 Filed Sep 1
  8. Hrt Financial LP 10% owner
    Sale
    $57K 8,299 shares at $6.91 95% of stake
    Traded Aug 28–31 Filed Sep 1
  9. Hrt Financial LP 10% owner
    Sale
    $2,078 419 shares at $4.96 4.2% of stake
    Traded Aug 27 Filed Aug 31
  10. Steven M Foster CEO
    Buy
    — 19,455 shares +568% to stake
    Traded Nov 14, 2025 Filed Nov 18, 2025
  11. Nathaniel A. Grawey Chief Commercial Officer
    Buy
    — 101,167 shares +73% to stake
    Traded Nov 14, 2025 Filed Nov 18, 2025

Also filed in the last 12 months, not counted as buying or selling: 19 option exercises, 9 share withholdings for taxes, and 2 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 1.01,9.01
424B5 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS
8-K 1.01,3.02,8.01,9.01
8-K 8.01,9.01
424B3 PROSPECTUS
8-K 1.01,3.02,8.01,9.01
8-K/A 1.01,3.02,8.01,9.01
8-K 8.01,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q QUARTERLY REPORT
8-K 3.03,5.03,7.01,9.01
8-K 5.07
8-K 8.01,9.01
8-K 8.01
SCHEDULE 13G —
8-K 1.01,8.01,9.01
424B4 PROSPECTUS
S-1/A AMENDMENT NO. 1 TO FORM S-1
DEF 14A DEFINITIVE PROXY STATEMENT
S-1 REGISTRATION STATEMENT
8-K 1.01,5.02,9.01
8-K 5.03,9.01
8-K 3.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.